A ninth Quebecer has suffered from vaccine-induced immune thrombotic thrombocytopenia, a rare blood-clotting syndrome, after receiving their first dose of the AstraZeneca-Oxford vaccine, the province's Health Ministry announced Tuesday. The patient received medical attention and is recovering well at home, the ministry says in a statement. Given the number of doses administered in Quebec, blood clots are still considered a possible, but rare complication of the AstraZeneca vaccine, the statement says. Approximately one in 50,000 people receiving their first shot may get a blood clot, the ministry says. Back in April, Quebec officials confirmed the death of a woman after the AstraZeneca vaccine she received in early April led to a rare blood clot in her brain.

Source: CBC News June 01, 2021 23:48 UTC